Simple Summary Hepatocellular carcinoma (HCC) is the most common type of liver cancer,
accounting for approximately 85–90% of all cases of liver cancer worldwide. The gut …

Hepatocellular carcinoma (HCC) ranks the third place among all causes inducing cancer-
associated mortality, worldwide. HCC nearly exclusively occurs in cases suffering from …

Hepatocellular carcinoma (HCC) is the most prevalent cancer and a leading cause of cancer-
related deaths worldwide. Chronic hepatitis B, hepatitis C, alcoholism, and non-alcohol fatty …

Liver cancer is a leading cause of death worldwide, and hepatocellular carcinoma (HCC) is
the most frequent primary liver tumour, followed by cholangiocarcinoma. Notably, secondary …

Simple Summary Hepatocellular carcinoma (HCC), the most common form of liver cancer, is
the third leading cause of cancer-related mortality worldwide. Recent research indicates that …

Hepatocellular carcinoma (HCC) is the world's third most prevalent cause of cancer-related
mortality. HCC frequently occurs in patients with chronic liver diseases, and it is triggered by …

Disruptions in the human gut microbiome have been associated with a cycle of hepatocyte
injury and regeneration characteristic of chronic liver disease. Evidence suggests that the …

The microbiome exerts essential functions in health and disease, modulating key processes
in metabolism, inflammation and immunity. Recent evidence has revealed a key role of the …

The recent evolution of immunotherapy has revolutionised the treatment of hepatocellular
carcinoma (HCC) and has led to new therapeutic standards. The advances in …

Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide. It is
usually the result of pre‐existing liver damage caused by hepatitis B and/or C virus infection …